The scope of the report includes an overview of the global market for nanoparticles in biotechnology, drug development and drug delivery, and analyses of global market trends, using 2019 as the base year and forecasting 2020 through 2025 with compound annual growth rate (CAGR) projections.
The report includes analysis of leading and emerging drug products for each nanoparticle type. Profiles of manufacturers of leading products and their specific products are provided. This report also assesses companies poised to introduce products during the forecast period and discusses how these introductions will change the face of the competitive environment. The competitive environment is examined with a special focus on how new products will alter the quality of life of patients receiving nanoparticle-associated drugs.
Market figures are based on revenues at the manufacturer level and are projected in 2019 dollar value. Inflation is not computed into the projection figures. Trends are assessed based on projected sales for existing products, for new product introductions, expanded markets for existing products, and other factors affecting the market included in this report are forecasts by product, product category and by company.
The study is arranged to offer an overview of existing nanoparticle technology and of drug markets; it is accompanied by nanoproduct, company, geography, and mechanism of action, with forecasts broken down and covered by geographic region or country.
Patent and clinical trial information is reviewed for various candidate nanodrugs. The status of approvals of drugs in each segment by the FDA and regulatory agencies in other countries is reviewed.
Figures are reported in U.S. dollars and in each case reflect currency fluctuations within the performance of revenue change. Revenue figures do not account for variation in local currencies. All market share data presented is on a global basis unless specifically noted.
Regional analysis includes North America (U.S., Canada, Mexico), Europe (U.K., Germany, France, Spain, Italy, Rest of Europe), Asia-Pacific (China, India, Japan, and Rest of Asia-Pacific), and the Rest of the world (South America, and the Middle East and Africa).
- 43 tables
- An overview of the global nanoparticles in biotechnology, drug development and drug delivery market
- Estimation of the market size and analyses of market trends, with data from 2019, estimates for 2020 and projection of CAGR through 2025
- Highlights of the drug development, formulation, and the development of new drug delivery systems and detailed product analyses within health and wellness subsegments
- Information on nanomedicine and biomedical nanoparticle products and coverage of the next generation vaccines
- Evaluation of current market trends, market size, market forecast, and detailed analysis of drivers, challenges, and opportunities affecting market growth
- Discussion on the role of nanotechnology in COVID-19 vaccine production, components, and methods in the vaccine design for COVID-19 and challenges for vaccine disruptions
- Assessment of various approaches for the treatment of COVID-19, and detailed description of structure and penetration of corona virus
- Details of clinical trials of nanoparticle drugs and drug delivery systems
- A look at the patents, licensing, mergers and acquisitions and market share analysis of the key companies of the industry
- Company profiles of major players including Bristol-Myers Squibb Co., GlaxoSmithKline PLC, Hofmann-La Roche Inc., Merck & Co., and Novartis AG
Nanoparticle technology has made major advances in particle type, production and application in all areas of the life sciences in the past two decades. The most rapid advances have been made in the application of nanoparticles in drug research and development, drug product formulation and development of novel drug delivery systems using nanoparticle carriers. The development of nanoparticles and their rapid incorporation into the research and development, formulation and production of drug products has given rise to a new area of biotechnology and pharmaceutical research involving particle materials in the nanometer size range.
Nanoparticles used in the life sciences and biomedical applications are usually considered to be in the range of 10 nanometers to 100 nanometers in diameter. Developing particles from various starting materials that remain stable in this size range has become one of the fastest growing and most potentially useful emerging technologies of the last several decades.
Both particle size and shape are important in the life sciences because the particle properties of biopharmaceutical products can impact a drug product in two ways: size and shape. Size and shape can have an influence on drug performance or efficacy in the body.
The methods for producing nanoparticles vary depending on the starting substrate materials and the size particle desired as a product. This report will provide an overview of various production methods and indicate new advances in the production area. At present, the U.S. holds the largest number of patents in the nanoparticle area. This is largely due to the early commercialization of some nanoparticle products by U.S. companies. It also reflects that the contribution to research and development of new ideas by American companies is larger than those by most other countries.
Europe is the second-largest market for nanoparticle drug technology. France, Germany, and the U.K. are the major contributors to its market share. Drug formulation and delivery is attracting new players in Europe, and this in turn will contribute to the market’s growth."
Table of Contents
Chapter 1 Introduction Study Goals and Objectives Reasons for Doing This Study Scope of Report Methodology Market Estimate Information Sources Primary Research Secondary Research Geographic Breakdown Analyst's Credentials BCC Custom Research Related BCC Research Reports Chapter 2 Summary and Highlights Chapter 3 Market Overview Introduction to Nanoparticles Liposomes Quantum Dots Dendrimers Macromolecule Nanoparticles Brief History of Nanoparticles Nanoparticles in Biotechnology Nanoparticles in Drug Development Nanoparticles in Drug Delivery Systems Nanoparticles in Diagnostic Imaging Major Players in Nanoparticle Drug Delivery Field Major Nanoparticle/Nanocrystal Drug Revenues Chapter 4 Market Breakdown by Product Type Nanoparticles in Biotechnology Nanoparticles in Drug Development Nanoparticles in Drug Delivery Systems Nanoparticles in Diagnostic Imaging Distribution of Nanobiotechnology and Nanomedicine Companies Chapter 5 Structure of Nanoparticles Adoption of Nanoparticles in Applied Markets Liquid Crystals Liquid Carriers Liposomes Dendrimers Chitosan and Alginate Nanocrystals Quantum Dots Application of Nanoparticles to Drugs Delivered Chapter 6 Production of Nanoparticles Methods of Nanoparticle Formation Self-Assembly Production Methods of Stabilization Methods of Drug Introduction Polymeric Nanoparticles Micelles Liposomes Gold and Silicon Nanoparticles Dendrimers Methods for Loading Biological Molecules into Nanoparticles Nanocrystal Drugs Problems with Large-Scale Nanoparticles Production Chapter 7 Nanoparticles in Biotechnology Research and Development Stem Cell Research Cellular Repair Paramagnetic and Superparamagnetic Nanoparticles Biosensors and Quantum Dots Nanoparticle Research Collaborative Programs Chapter 8 Nanoparticles in Drug Development and Formulation Bio Separations Rapid Drug Analysis Removal of Impurities and Toxins Using Nanoparticles to Incorporate Insoluble Drugs Gold and Silver Nanoparticles in Biomedicine DNA Nanoparticle Development of DNA-Specific Drugs Chapter 9 Nanoparticles in Drug Delivery Systems Nanoparticles in Drug Delivery Applications Designing a Nanoparticle Drug Delivery System Nanoparticle Drug Stability Size Homogeneity of Nanoparticle Preparations Drug Loading of Nanoparticles Drug Release from Nanoparticles External Triggers for Releasing Drugs from Nanoparticles Binding/Incorporation of Biomolecules to Nanoparticles Nanoparticle Toxicity Large Scale Manufacturing Methods of Administration of Nanoparticle Drugs Oral Administration Injection Administration Transdermal Patch Implantation Administration Inhalation Administration Nanoparticles Suitable for Drug Delivery Systems Lipid-Based Nanoparticles Micelle Nanoparticles Dendrimer Nanoparticles Polymeric Nanoparticles Metal-Based Nanoparticles Biological Macromolecule Nanoparticles Nanocrystals Nanoparticle Drug Delivery Systems Now Available Antibiotic Nanoparticles Anti-Tumor and Small Molecule Delivery by Nanoparticle Release of Anti-Cancer Drugs from Nanoparticles Biomacromolecules Delivered by Nanoparticles Nanoparticles Coating for Drug Delivery Systems Removal of Nanoparticles from the body Chapter 10 In Vitro and In Vivo Diagnostic Imaging In Vitro Imaging Nanoparticles in Diagnostic Imaging Chapter 11 Biomedical Nanoparticle Products Nanoparticle Drug Delivery Systems and Products Major Players in Nanoparticle Drug Delivery Systems Company Pipelines for Nanoparticle Drug Delivery Drivers of Nanoparticle Products and Marketing Limiters of Nanoparticle Product Development and Marketing Chapter 12 Market Breakdown by Region Market Overview and Discussion North America Europe Asia-Pacific Rest of the World South America Middle East and Africa Chapter 13 Role of Nanotechnology in COVID-19 Vaccine Production Introduction Novel Coronavirus Relying on Various Approaches Structure of COVID-19 and Penetration Challenges for COVID-19 Vaccines Components and Methods in the Design of Vaccines Antigen Adjuvant Nanoparticle/Nanocarrier Device Next Generation Vaccines Enabled Through Advances in Nanotechnology Conclusion on Nanotechnology Usage Against COVID-19 Chapter 14 Patents, Licensing, Mergers and Acquisitions Recent Licensed, Mergers and Acquisition Recent Licensing Activity, Mergers and Acquisition Recent Deals Nanoparticle Patents Chapter 15 Company Profiles BRISTOL-MYERS SQUIBB CO. CAMURUS AB CERAMISPHERE PTY LTD. CYTIMMUNE SCIENCES GLAXOSMITHKLINE PLC. HOFFMANN-LA ROCHE INC. MERCK & CO. INC. NANOCARRIER CO. LTD. NOVARTIS AG
List of Tables Summary Table : Global Market for Nanoparticles in Biotechnology, Drug Development and Drug Delivery, by Product Type, Through 2025 Table 1 : Description of Nanoparticles Used in Drug Delivery and Diagnostic Imaging Table 2 : Applications of Nanoparticles in Biotechnology Table 3 : Applications of Nanoparticles in Drug Development Table 4 : Applications of Nanoparticles in Drug Delivery Systems Table 5 : Nanoparticles Used in Drug Delivery Systems Table 6 : Nanoparticles Used for In vivo Diagnostic Imaging Table 7 : Major Players in Nanoparticle Drug Field Table 8 : Major Nanoparticle/Nanocrystal Drug by Product and Company Table 9 : Global Market for Nanoparticles in Biotechnology, Through 2025 Table 10 : Global Market for Nanoparticles in Drug Development and Formulation, Through 2025 Table 11 : Global Market for Nanoparticles in Drug Delivery Systems, Through 2025 Table 12 : Global Market for Nanoparticles in Diagnostic Imaging Systems, Through 2025 Table 13 : Global Distribution of Nanobiotechnology and Nanomedicine Companies Table 14 : Nanoparticles Structure and Properties Table 15 : Nanoparticles Systems Approved for Drug Delivery Table 16 : Sample of Drugs Delivered Through Liposome Nanotechnology Table 17 : Nanoparticles in Biotechnology Applications Table 18 : Nano Biosensor Technology Under Development Table 19 : ETPN Strategic Research and Innovation Agenda Table 20 : Nanoparticles in Drug Development Applications Table 21 : Monoclonal antibody (mAb) Drugs with Potential for Use in Nanoparticles Delivery Systems Table 22 : Solid Lipid Nanoparticles-Reformatted Drugs Table 23 : Nanoparticles in Drug Delivery Applications Table 24 : Standard Routes of Drug Administration Table 25 : Nanoparticle Transdermal Patch Products Table 26 : Type of Nanoparticles Supplied in Drug Delivery Systems Table 27 : Mechanism for Removal of Nanoparticles from the Body Table 28 : Nanoparticles Contrast Media Used for In Vivo Diagnostic Imaging Table 29 : List of Marketed Products Used in Different Nanotechnology-based Techniques Table 30 : Major Players in Nanoparticle Drug Development and Formulation Market Table 31 : Company Pipeline for Cardiovascular Nanoparticle Drugs Table 32 : Company Pipeline for CNS Disease Nanoparticle Drugs Table 33 : Company Pipeline for GI Disease Nanoparticle Drugs Table 34 : Company Pipeline for Infectious Disease Nanoparticle Drugs Table 35 : Company Pipeline for Cancer Nanoparticle Drugs Table 36 : Company Pipeline for Ophthalmic Nanoparticle Drugs Table 37 : Company Pipeline for Autoimmune Disease Nanoparticle Drugs Table 38 : Global Market for Nanoparticles in Biotechnology, Drug Development and Drug Delivery, by Region, Through 2025 Table 39 : North American Market for Nanoparticles in Biotechnology, Drug Development and Drug Delivery Systems, by Country, Through 2025 Table 40 : European Market for Nanoparticles in Biotechnology, Drug Development and Drug Delivery Systems, by Country, Through 2025 Table 41 : Asia-Pacific Market for Nanoparticles in Biotechnology, Drug Development and Drug Delivery Systems, by Country, Through 2025 Table 42 : Global Nanotechnology, Patents, by Country, 2017-2020 Table 43 : Bristol-Myers Squibb Co.: Financials, 2017-2019
List of Figures Summary Figure : Global Market for Nanoparticles in Biotechnology, Drug Development and Drug Delivery, by Product Type, 2019-2025 Figure 1 : Global Market for Nanoparticles in Biotechnology, Drug Development and Drug Delivery Systems, 2019-2025 Figure 2 : Global Market for Nanoparticles in Biotechnology, Drug Development and Drug Delivery Systems, by Region, 2019-2025 Figure 3 : Global Market Share for Nanoparticles in Biotechnology, Drug Development and Drug Delivery Systems, by Region, 2019 Figure 4 : North American Market for Nanoparticles in Biotechnology, Drug Development and Drug Delivery Systems, 2019-2025 Figure 5 : North American Market Shares of Nanoparticles in Biotechnology, Drug Development and Drug Delivery Systems, by Country, 2019 Figure 6 : European Market for Nanoparticles in Biotechnology, Drug Development and Drug Delivery Systems, 2019-2025 Figure 7 : European Market Shares of Nanoparticles in Biotechnology, Drug Development and Drug Delivery Systems, by Country, 2019 Figure 8 : Asia-Pacific Market for Nanoparticles in Biotechnology, Drug Development and Drug Delivery Systems, 2019-2025 Figure 9 : Asia-Pacific Market Shares of Nanoparticles in Biotechnology, Drug Development and Drug Delivery Systems, by Country, 2019 Figure 10 : South American Market for Nanoparticles in Biotechnology, Drug Development and Drug Delivery Systems, 2019-2025 Figure 11 : Middle Eastern and African Market for Nanoparticles in Biotechnology, Drug Development and Drug Delivery Systems, 2019-2025
Write comment about above report:
Published By: BCC Research
Did you find what you are/were looking for
If not, read below and browse through other relevant pages for similar market research
reports OR get in touch with us through the form/contact info in your right navigation
panel and well share relevant market report titles for you to explore.
We are on:
500,000 market research reports and growing.
Top Fortune 500 Organizations trust us for research data.
24/7 support on call as well as emails.
Your Details are safe with us.
Free support for your research requirements.
Report Delivery: Email
Upto 24 hrs - working days
Upto 48 hrs max - weekends and public holidays
Buy Any Report Avail 25% Discount. Coupon Code: JAN25